2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Respiratory Distress Syndrome
1
Prostatic Neoplasms
1
Pneumonia, Viral
1
Oligodendroglioma
1
Melanoma
1
Hodgkin Disease
1
High-Grade Anal Intraepithelial Neoplasia
1
Hematologic Neoplasms
1
HIV Infections
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Cytokine Release Syndrome
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Astrocytoma
1
Acquired Immunodeficiency Syndrome
1
Interventions
tocilizumab
2
Etanercept
2
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Immunoglobulin G
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Electromyography
1
Disulfides
1
Blood Specimen Collection
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Distress Syndrome
×
Lopinavir
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled